Physician
Abdulmassih, Abdulmassih
Abdulmassih, Abdulmassih was paid $3.30M by Medicaid between Jan 2018 and Dec 2024, across 82 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 37% of everything it billed.
33Billing provider infoABDULMASSIH, ABDULMASSIH
CHICAGO, IL 60646
CHICAGO, IL 60646
33aNPI1629045778assigned 03/07/2006
33bProvider typeFamily Medicine Physician
28Total paid$3.30M
24GClaims113,611
24DCodes billed82
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Illinois
Rank by total paid#25 of 2,947
Median peer was paid$43K
This provider vs. median77×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,049 | $759K | |
| 2019 | 14,806 | $193K | |
| 2020 | 17,532 | $425K | |
| 2021 | 17,292 | $511K | |
| 2022 | 16,897 | $575K | |
| 2023 | 10,657 | $411K | |
| 2024incomplete | 9,378 | $425K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 26,694 | 20,696 | $1.23M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 29,004 | 20,797 | $920K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 10% | 4,317 | 3,755 | $335K |
| 99397 | 4.8% | 2,532 | 2,333 | $158K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.4% | 1,733 | 1,496 | $145K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 2.2% | 3,689 | 2,886 | $74K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.7% | 1,981 | 556 | $55K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.3% | 538 | 374 | $42K |
| 92552 | 1.0% | 2,084 | 1,472 | $34K | |
| 90662 | 1.0% | 1,237 | 1,015 | $33K | |
| 93000 | <1% | 1,634 | 1,354 | $26K | |
| 99386 | <1% | 243 | 141 | $23K |
70 more codes
| 0240U | <1% | 207 | $21K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,625 | $19K |
| 0012A | <1% | 583 | $18K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 246 | $18K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,106 | $15K |
| 90686 | <1% | 993 | $15K | |
| 99223 | Prolong inpt eval add15 m | <1% | 207 | $14K |
| 0011A | <1% | 645 | $12K | |
| 99173 | <1% | 1,871 | $11K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 264 | $9K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 56 | $7K |
| 90688 | <1% | 475 | $7K | |
| 99385 | <1% | 64 | $7K | |
| 0064A | <1% | 215 | $6K | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 945 | $6K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,533 | $5K |
| 90732 | <1% | 152 | $4K | |
| G0247 | Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds, (2) debridement of corns and calluses, and (3) trimming and debridement of nails | <1% | 520 | $4K |
| G0246 | Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education | <1% | 441 | $3K |
| 69210 | <1% | 183 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 110 | $2K |
| 99306 | Prolong nursin fac eval 15m | <1% | 98 | $2K |
| 0134A | <1% | 64 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 2,660 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 36 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 123 | $2K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 59 | $1K |
| 81003 | <1% | 1,350 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,661 | $1K |
| 20610 | <1% | 206 | $1K | |
| 83014 | <1% | 165 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,456 | $1K |
| 0013A | <1% | 27 | $750.68 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 222 | $711.88 |
| 80061 | Lipid panel | <1% | 1,450 | $513.25 |
| 90670 | <1% | 91 | $501.40 | |
| G0008 | Administration of influenza virus vaccine | <1% | 549 | $499.84 |
| 94060 | <1% | 24 | $464.17 | |
| 0002A | <1% | 13 | $445.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 56 | $406.00 |
| 81001 | <1% | 1,002 | $371.03 | |
| 90649 | <1% | 57 | $352.00 | |
| 90672 | <1% | 44 | $322.56 | |
| 85610 | <1% | 170 | $263.64 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,236 | $213.75 |
| 90734 | <1% | 23 | $147.20 | |
| 82274 | <1% | 48 | $140.00 | |
| 90620 | <1% | 21 | $128.00 | |
| 82962 | <1% | 1,276 | $108.26 | |
| 82044 | <1% | 1,223 | $96.15 | |
| 64418 | <1% | 23 | $73.44 | |
| 64445 | <1% | 48 | $73.39 | |
| 36410 | <1% | 12 | $70.13 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 88 | $56.40 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 589 | $32.00 |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 14 | $12.50 |
| 90461 | <1% | 145 | $12.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 20 | $7.50 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 166 | $1.67 |
| 64413 | <1% | 23 | $0.14 | |
| 3074F | 0% | 86 | $0.00 | |
| 91301 | 0% | 571 | $0.00 | |
| 91306 | 0% | 35 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 51 | $0.00 |
| 99443 | 0% | 27 | $0.00 | |
| 99442 | 0% | 106 | $0.00 | |
| A4550 | Surgical trays | 0% | 940 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 14 | $0.00 |
| 3078F | 0% | 83 | $0.00 | |
| 91300 | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.